Association of HLA-DR genotypes and IL-1ra gene polymorphism with treatment failure of budesonide and disease patterns in Crohn's disease

Gelbmann, Cornelia M. and Rogler, Gerhard and Gierend, Michael and Gross, Volker and Schoelmerich, Juergen and Andus, Tilo (2001) Association of HLA-DR genotypes and IL-1ra gene polymorphism with treatment failure of budesonide and disease patterns in Crohn's disease. EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY, 13 (12). pp. 1431-1437. ISSN 0954-691X

Full text not available from this repository. (Request a copy)

Abstract

Objective Associations between HLA-DR genotypes and susceptibility to Crohn's disease (CID) have been reported. However, it is not known whether certain HLA-DR genotypes or IL-1ra gene polymorphism are associated with responsiveness to treatment or different clinical patterns of disease. Design/setting In a large, randomized, controlled multicentre trial, 318 patients with CD were treated with daily doses of 6, 9 or 18 mg budesonide. Patients were stratified into two groups: patients without steroid pretreatment and with active CID (CDAI > 150) and patients with conventional steroid pretreatment of less than or equal to 30 mg prednisolone per day, which was replaced by oral budesonide within 3 weeks. Main outcome measures The HLA-DRB1 genotypes 1-16 and the IL-1ra gene polymorphism were examined for an association with budesonide treatment failure. Results Only HLA-DR 8 was associated with treatment failure of budesonide. HLA-DR 8 is not very common. Only 17/243 patients who could be evaluated expressed this genotype, and 13 of these 17 patients did not respond to budesonide (P < 0.00067). Neither the other HLA-DR genotypes nor the IL-1ra gene polymorphisim had an influence on treatment outcome of budesonide therapy. No significant association of fistulas, perianal disease, need for bowel resections, and disease localization with certain HLA-DRB1 genotypes or the IL-1ra gene polymorphism were found. Conclusions This is the first description of an association of a certain HLA-DR genotype (HLA-DR 8) with treatment failure in inflammatory bowel disease (IBD). (C) 2001 Lippincott Williams & Wilkins.

Item Type: Article
Uncontrolled Keywords: INFLAMMATORY-BOWEL-DISEASE; ORAL BUDESONIDE; INTESTINAL INFLAMMATION; CLINICAL-PATTERNS; SUSCEPTIBILITY; CLASSIFICATION; PREDNISOLONE; MESALAMINE; DEPENDENCY; IMBALANCE; budesonide; Crohn's disease; disease heterogeneity; HLA-DR; interleukin-1 receptor antagonist; prognostic factors; steroid resistance
Subjects: 600 Technology > 610 Medical sciences Medicine
Divisions: Medicine > Lehrstuhl für Innere Medizin I
Depositing User: Dr. Gernot Deinzer
Date Deposited: 23 Nov 2021 11:23
Last Modified: 23 Nov 2021 11:23
URI: https://pred.uni-regensburg.de/id/eprint/40892

Actions (login required)

View Item View Item